Cargando…
Targeted Gene Delivery: Where to Land
Genome-editing technologies have the potential to correct most genetic defects involved in blood disorders. In contrast to mutation-specific editing, targeted gene insertion can correct most of the mutations affecting the same gene with a single therapeutic strategy (gene replacement) or provide nov...
Autores principales: | Pavani, Giulia, Amendola, Mario |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8525409/ https://www.ncbi.nlm.nih.gov/pubmed/34713234 http://dx.doi.org/10.3389/fgeed.2020.609650 |
Ejemplares similares
-
Corrigendum: Targeted Gene Delivery: Where to Land
por: Pavani, Giulia, et al.
Publicado: (2021) -
Advances in Delivery Mechanisms of CRISPR Gene-Editing Reagents in Plants
por: Laforest, Larissa C., et al.
Publicado: (2022) -
Gene Therapy: The Next-Generation Therapeutics and Their Delivery Approaches for Neurological Disorders
por: Paul, Abhik, et al.
Publicado: (2022) -
Gene Editing and Genotoxicity: Targeting the Off-Targets
por: Blattner, Georges, et al.
Publicado: (2020) -
Current approaches and potential challenges in the delivery of gene editing cargos into hematopoietic stem and progenitor cells
por: Murugesan, Ramya, et al.
Publicado: (2023)